These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
162 related items for PubMed ID: 30471971
1. Clostridioides difficile colonization and infection in patients with newly diagnosed acute leukemia: Incidence, risk factors, and patient outcomes. Ford CD, Lopansri BK, Webb BJ, Coombs J, Gouw L, Asch J, Hoda D. Am J Infect Control; 2019 Apr; 47(4):394-399. PubMed ID: 30471971 [Abstract] [Full Text] [Related]
2. Clostridioides difficile colonization and infection in patients admitted for a first autologous transplantation: Incidence, risk factors, and patient outcomes. Ford CD, Lopansri BK, Coombs J, Webb BJ, Nguyen A, Asch J, Hoda D. Clin Transplant; 2019 Nov; 33(11):e13712. PubMed ID: 31532030 [Abstract] [Full Text] [Related]
5. Increasing prevalence of the epidemic ribotype 106 in healthcare facility-associated and community-associated Clostridioides difficile infection. Suárez-Bode L, Barrón R, Pérez JL, Mena A. Anaerobe; 2019 Feb; 55():124-129. PubMed ID: 30550807 [Abstract] [Full Text] [Related]
6. The epidemiology of Clostridioides difficile infection in Brazil: A systematic review covering thirty years. Trindade CNR, Domingues RMCP, Ferreira EO. Anaerobe; 2019 Aug; 58():13-21. PubMed ID: 30851427 [Abstract] [Full Text] [Related]
7. Association of healthcare exposure with acquisition of different Clostridium difficile strain types in patients with recurrent infection or colonization after clinical resolution of initial infection. Thabit AK, Housman ST, Burnham CD, Nicolau DP. J Hosp Infect; 2016 Feb; 92(2):167-72. PubMed ID: 26792686 [Abstract] [Full Text] [Related]
8. Risk factors for Clostridioides difficile infection and colonization among patients admitted to an intensive care unit in Shanghai, China. Cui Y, Dong D, Zhang L, Wang D, Jiang C, Ni Q, Wang C, Mao E, Peng Y. BMC Infect Dis; 2019 Nov 11; 19(1):961. PubMed ID: 31711425 [Abstract] [Full Text] [Related]
9. Examining the epidemiology and microbiology of Clostridium difficile carriage in elderly patients and residents of a healthcare facility in southern Ontario, Canada. Mallia G, Van Toen J, Rousseau J, Jacob L, Boerlin P, Greer A, Metcalf D, Weese JS. J Hosp Infect; 2018 Aug 11; 99(4):461-468. PubMed ID: 29408207 [Abstract] [Full Text] [Related]
10. A prospective study of community-associated Clostridium difficile infections: the role of antibiotics and co-infections. Taori SK, Wroe A, Hardie A, Gibb AP, Poxton IR. J Infect; 2014 Aug 11; 69(2):134-44. PubMed ID: 24780765 [Abstract] [Full Text] [Related]
11. Clinical features and characteristics of Clostridium difficile PCR-ribotype 176 infection: results from a 1-year university hospital internal ward study. Drabek J, Nyc O, Krutova M, Stovicek J, Matejkova J, Keil R. Ann Clin Microbiol Antimicrob; 2015 Dec 23; 14():55. PubMed ID: 26698842 [Abstract] [Full Text] [Related]
12. Incidence of Clostridium difficile infection in patients receiving high-risk antibiotics with or without a proton pump inhibitor. Gordon D, Young LR, Reddy S, Bergman C, Young JD. J Hosp Infect; 2016 Feb 23; 92(2):173-7. PubMed ID: 26616410 [Abstract] [Full Text] [Related]
13. Burden of Clostridium difficile infection between 2010 and 2013: Trends and outcomes from an academic center in Eastern Europe. Kurti Z, Lovasz BD, Mandel MD, Csima Z, Golovics PA, Csako BD, Mohas A, Gönczi L, Gecse KB, Kiss LS, Szathmari M, Lakatos PL. World J Gastroenterol; 2015 Jun 07; 21(21):6728-35. PubMed ID: 26074711 [Abstract] [Full Text] [Related]
14. High morbidity and mortality of Clostridium difficile infection and its associations with ribotype 002 in Hong Kong. Wong SH, Ip M, Hawkey PM, Lo N, Hardy K, Manzoor S, Hui WW, Choi KW, Wong RY, Yung IM, Cheung CS, Lam KL, Kwong T, Wu WK, Ng SC, Wu JC, Sung JJ, Lee N. J Infect; 2016 Aug 07; 73(2):115-22. PubMed ID: 27246801 [Abstract] [Full Text] [Related]
15. Incidence, outcome, and risk factors for recurrence of nosocomial Clostridioides difficile infection in adults: A prospective cohort study. Karaoui WR, Rustam LBO, Bou Daher H, Rimmani HH, Rasheed SS, Matar GM, Mahfouz R, Araj GF, Zahreddine N, Kanj SS, Berger FK, Gärtner B, El Sabbagh R, Sharara AI. J Infect Public Health; 2020 Apr 07; 13(4):485-490. PubMed ID: 31838001 [Abstract] [Full Text] [Related]
16. Universal screening for Clostridioides difficile in a tertiary hospital: risk factors for carriage and clinical disease. Meltzer E, Smollan G, Huppert A, Fluss R, Tal I, Gilboa M, Zilberman-Daniels T, Keller N, Rahav G, Regev-Yochay G, SHIC research group. Clin Microbiol Infect; 2019 Sep 07; 25(9):1127-1132. PubMed ID: 30771530 [Abstract] [Full Text] [Related]
17. Investigation of Clostridium difficile ribotypes in symptomatic patients of a German pediatric oncology center. Simon A, Mock M, Graf N, von Müller L. Eur J Pediatr; 2018 Mar 07; 177(3):403-408. PubMed ID: 29273940 [Abstract] [Full Text] [Related]
18. Whole-genome sequencing improves discrimination of relapse from reinfection and identifies transmission events among patients with recurrent Clostridium difficile infections. Mac Aogáin M, Moloney G, Kilkenny S, Kelleher M, Kelleghan M, Boyle B, Rogers TR. J Hosp Infect; 2015 Jun 07; 90(2):108-16. PubMed ID: 25935700 [Abstract] [Full Text] [Related]
19. Asymptomatic and yet C. difficile-toxin positive? Prevalence and risk factors of carriers of toxigenic Clostridium difficile among geriatric in-patients. Nissle K, Kopf D, Rösler A. BMC Geriatr; 2016 Nov 15; 16(1):185. PubMed ID: 27846818 [Abstract] [Full Text] [Related]
20. Molecular characteristics of Clostridium difficile strains from patients with a first recurrence more than 8 weeks after the primary infection. Chen Y, Rashid MU, Huang H, Fang H, Nord CE, Wang M, Weintraub A. J Microbiol Immunol Infect; 2017 Aug 15; 50(4):532-536. PubMed ID: 26698688 [Abstract] [Full Text] [Related] Page: [Next] [New Search]